Marinus Pharmaceuticals expects to reel in $60M from stock, warrants sale
By John George – Senior Reporter, Philadelphia Business Journal
Nov 10, 2022Listen to this article 2 min
Marinus Pharmaceuticals expects to close a $60 million public stock offering today.
The Radnor company is selling slightly more than $10.5 million shares of common stock at $4.75 per share. Additionally, it is selling to certain investors, in lieu of common stock, pre-funded warrants to purchase 2.1 million shares of common stock at a price of $4.75.
The amount of the offering could grow by another $9 million if underwriters exercise in full their option to purchase an additional $1.9 million shares to cover overallotments.
Read the full article at: www.bizjournals.com
